Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

NCT00664430 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00664430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00664430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2009
Completion date
June 30, 2009
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis, secondary hyperparathyroidism